Literature DB >> 16478368

Managing oncology costs.

Claiborne E Reeder1, Debra Gordon.   

Abstract

This monograph will review the burden of illness in oncology, suggest a framework for evaluating oncology costs and consequences, identify economic modeling formats in cancer care, and explore methods of cost control for cancer care.

Entities:  

Mesh：

Year:  2006        PMID： 16478368

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN： 1088-0224            Impact factor:   2.229


  7 in total

1.  The importance of cost inputs and sensitivity analyses in a cost-effectiveness analysis.

Authors:  Jenna L Yoder Pharmd
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

Review 2.  Current challenges in health economic modeling of cancer therapies: a research inquiry.

Authors:  Jeffrey D Miller; Kathleen A Foley; Mason W Russell
Journal:  Am Health Drug Benefits       Date:  2014-05

Review 3.  The Therapeutic Potential of Mesenchymal Stromal Cells in the Treatment of Chemotherapy-Induced Tissue Damage.

Authors:  Alexander Rühle; Ramon Lopez Perez; Bingwen Zou; Anca-Ligia Grosu; Peter E Huber; Nils H Nicolay
Journal:  Stem Cell Rev Rep       Date:  2019-06       Impact factor: 5.739

Review 4.  Can the Spanish care system assume the new costs of medications against cancer?

Authors:  Carlos Camps; Cristina Caballero; Rafael Sirera; Ana Blasco; Diego Cayuela; Mireia Gil; Xavier Badía
Journal:  Clin Transl Oncol       Date:  2008-02       Impact factor: 3.405

5.  The cost of systemic therapy for metastatic colorectal carcinoma in Slovenia: discrepancy analysis between cost and reimbursement.

Authors:  Tanja Mesti; Biljana Mileva Boshkoska; Mitja Kos; Metka Tekavčič; Janja Ocvirk
Journal:  Radiol Oncol       Date:  2015-03-25       Impact factor: 2.991

6.  Drug waste minimisation and cost-containment in Medical Oncology: two-year results of a feasibility study.

Authors:  Gianpiero Fasola; Marianna Aita; Luisa Marini; Alessandro Follador; Marina Tosolini; Laura Mattioni; Mauro Mansutti; Andrea Piga; Silvio Brusaferro; Giuseppe Aprile
Journal:  BMC Health Serv Res       Date:  2008-04-01       Impact factor: 2.655

7.  Trends in annual drug expenditure - a 16 year perspective of a public healthcare maintenance organization.

Authors:  Yossef Lomnicky; Daniel Kurnik; Ronen Loebstein; Itzhak Katzir; Janet Vesterman-Landes; Nava Siegelmann-Danieli
Journal:  Isr J Health Policy Res       Date:  2016-09-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.